Evaxion A/S (EVAX)
NASDAQ: EVAX · Real-Time Price · USD
2.930
-0.150 (-4.87%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Evaxion Market Cap
Evaxion has a market cap or net worth of $24.44 million as of October 30, 2026. It is the 35,328th most valuable company in the world and the 5,088th biggest in the United States. Its market cap has decreased by 32.72% in one year.
Market Cap
24.44M
Enterprise Value
17.54M
1-Year Change
-32.72%
Global Rank
Country Rank
#5,088 United States
Category
ChartMarket Cap Chart
Since the IPO on February 5, 2021, Evaxion's market cap has decreased from $191.99M to $24.44M, a decrease of -87.27%. That is a compound annual growth rate of -30.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 24.44M | -38.57% |
| Dec 31, 2025 | 39.78M | 702.21% |
| Dec 31, 2024 | 4.96M | -80.92% |
| Dec 29, 2023 | 25.99M | -39.34% |
| Dec 30, 2022 | 42.84M | -58.12% |
| Dec 31, 2021 | 102.29M | -46.72% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TransCode Therapeutics | 27.60M |
| BriaCell Therapeutics | 26.57M |
| BeyondSpring | 26.47M |
| Polyrizon | 26.11M |
| ABVC BioPharma | 25.96M |
| Celularity | 25.96M |
| CEL-SCI | 24.27M |
| CervoMed | 24.19M |